Clinical Trial Update: A Pilot Study of Oral Tinidazole for Women With Recurrent Bacterial Vaginosis [Phase 2]

View source ↗

Summary

A Phase 2 pilot study of oral tinidazole for recurrent bacterial vaginosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• Tinidazole (tinidazole)

Snippet

Sponsor: Kaiser Permanente | Conditions: Recurrent Bacterial Vaginosis | Phase 2 | Status: WITHDRAWN